381 related articles for article (PubMed ID: 17034300)
1. Generating monodisperse pharmacological aerosols using the spinning-top aerosol generator.
Biddiscombe MF; Barnes PJ; Usmani OS
J Aerosol Med; 2006; 19(3):245-53. PubMed ID: 17034300
[TBL] [Abstract][Full Text] [Related]
2. A system for the production and delivery of monodisperse salbutamol aerosols to the lungs.
Biddiscombe MF; Usmani OS; Barnes PJ
Int J Pharm; 2003 Mar; 254(2):243-53. PubMed ID: 12623200
[TBL] [Abstract][Full Text] [Related]
3. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
[TBL] [Abstract][Full Text] [Related]
4. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
5. Sub-micrometer particle production by pressurized metered dose inhalers.
Crampton M; Kinnersley R; Ayres J
J Aerosol Med; 2004; 17(1):33-42. PubMed ID: 15120011
[TBL] [Abstract][Full Text] [Related]
6. Comparison of nebulized particle size distribution with Malvern laser diffraction analyzer versus Andersen cascade impactor and low-flow Marple personal cascade impactor.
Kwong WT; Ho SL; Coates AL
J Aerosol Med; 2000; 13(4):303-14. PubMed ID: 11262437
[TBL] [Abstract][Full Text] [Related]
7. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.
Waldrep JC; Berlinski A; Dhand R
J Aerosol Med; 2007; 20(3):310-9. PubMed ID: 17894537
[TBL] [Abstract][Full Text] [Related]
9. Effects of bronchodilator particle size in asthmatic patients using monodisperse aerosols.
Usmani OS; Biddiscombe MF; Nightingale JA; Underwood SR; Barnes PJ
J Appl Physiol (1985); 2003 Nov; 95(5):2106-12. PubMed ID: 12897033
[TBL] [Abstract][Full Text] [Related]
10. Electrostatic charge characteristics of jet nebulized aerosols.
Kwok PC; Trietsch SJ; Kumon M; Chan HK
J Aerosol Med Pulm Drug Deliv; 2010 Jun; 23(3):149-59. PubMed ID: 20500092
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the generation of radiolabeled monodisperse albuterol particles using the spinning-top aerosol generator.
Usmani OS; Biddiscombe MF; Underwood SR; Barnes PJ
J Nucl Med; 2004 Jan; 45(1):69-73. PubMed ID: 14734675
[TBL] [Abstract][Full Text] [Related]
12. Influence of flow rate on aerosol particle size distributions from pressurized and breath-actuated inhalers.
Smith KJ; Chan HK; Brown KF
J Aerosol Med; 1998; 11(4):231-45. PubMed ID: 10346666
[TBL] [Abstract][Full Text] [Related]
13. Size distribution of salbutamol/ipratropium aerosols produced by different nebulizers in the absence and presence of heat and humidification.
Yang SH; Yang TM; Lin HL; Tsai YH; Fang TP; Wan GH
Pulm Pharmacol Ther; 2018 Feb; 48():22-27. PubMed ID: 29054517
[TBL] [Abstract][Full Text] [Related]
14. Aerosol particle generation from dry powder inhalers: can they equal pressurized metered dose inhalers?
Olsson B
J Aerosol Med; 1995 Sep; 8 Suppl 3():S13-8; discussion S19. PubMed ID: 10172642
[TBL] [Abstract][Full Text] [Related]
15. Co-deposition of a triple therapy drug formulation for the treatment of chronic obstructive pulmonary disease using solution-based pressurised metered dose inhalers.
Adi H; Young PM; Traini D
J Pharm Pharmacol; 2012 Sep; 64(9):1245-53. PubMed ID: 22881437
[TBL] [Abstract][Full Text] [Related]
16. Application of a droplet evaporation model to aerodynamic size measurement of drug aerosols generated by a vibrating mesh nebulizer.
Rao N; Kadrichu N; Ament B
J Aerosol Med Pulm Drug Deliv; 2010 Oct; 23(5):295-302. PubMed ID: 20455771
[TBL] [Abstract][Full Text] [Related]
17. A new approach to characterise pharmaceutical aerosols: measurement of aerosol from a single dose aqueous inhaler with an optical particle counter.
Kuhli M; Weiss M; Steckel H
Eur J Pharm Sci; 2010 Jan; 39(1-3):45-52. PubMed ID: 19874891
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of aerosol size during inhalation: hygroscopic growth of commercial nebulizer formulations.
Haddrell AE; Davies JF; Miles RE; Reid JP; Dailey LA; Murnane D
Int J Pharm; 2014 Mar; 463(1):50-61. PubMed ID: 24406674
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of a low-dose, monodisperse parasympathicolytic aerosol compared with a standard aerosol from a metered-dose inhaler.
Zanen P; Go LT; Lammers JW
Eur J Clin Pharmacol; 1998 Mar; 54(1):27-30. PubMed ID: 9591926
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
